Skip to main content

Table 2 Outcomes of Antituberculosis and Antiretroviral Treatment

From: Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment

Outcome of ATT at 6 months/completion

Outcome

Early ART (n = 88)

Delayed ART (n = 62)

P value

Successfully treated

93.4% (71/76)

93.1% (54/58)

0.105 (Overall)

Failure

6.6% (5/76)

5.2% (3/58)

 

Treatment Modified

1.3% (1/76)

1.7% (1/58)

 

Losses during ATT:

   

Died

06 (6.8%)

04 (6.4%)

 

Lost to Follow Up

06 (6.8%)

00 (0.0%)

 

Outcome of ART at 12 months

Outcome

Early ART (n = 88)

Delayed ART (n = 62)

P value

HIV Disease Progression

14 (16%)

19 (31%)

0.045

Clinical Failure

00 (0%)

01 (1.6%)

0.413

Immunological failure

08 (9.1%)

14 (22.6%)

0.033

Virological failure

08 (09.1%)

08 (12.9%)

0.592

Lost to follow up

11 (12.5%)

01 (1.6%)

 
  1. ART = Antiretroviral therapy, ATT = Antituberculosis treatment.